BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/13/2021 10:05:39 AM | Browse: 504 | Download: 976
 |
Received |
|
2021-01-24 20:49 |
|
Peer-Review Started |
|
2021-01-24 20:53 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-02-22 06:09 |
|
Revised |
|
2021-02-22 16:24 |
|
Second Decision |
|
2021-04-08 12:57 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-04-14 04:17 |
|
Articles in Press |
|
2021-04-14 04:17 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-04-21 03:40 |
|
Typeset the Manuscript |
|
2021-05-12 00:11 |
|
Publish the Manuscript Online |
|
2021-05-13 10:05 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Research & Experimental Medicine |
| Manuscript Type |
Review |
| Article Title |
Receptor for advanced glycation end-products axis and COVID-19 in inflammatory bowel diseases: A dangerous liaison?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Armando Rojas, Iván Schneider, Cristian Lindner, Ileana Gonzàlez and Miguel Angel Morales |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Armando Rojas, PhD, Full Professor, Biomedical Research Labs, Medicine Faculty, Catholic University of Maule, 3605 San Miguel Ave, Talca 3634000, Chile. arojasr@ucm.cl |
| Key Words |
COVID-19; Inflammatory bowel diseases; Advanced glycation; Angiotensin-converting enzyme 2; Alarmins; Receptor for advanced glycation end-products; Receptor for advanced glycation end-products axis; Inflammation |
| Core Tip |
Data raised during the pandemic suggest that inflammatory bowel diseases (IBD) do not have an increased risk of contracting severe acute respiratory syndrome coronavirus 2 infection or develop a more severe course of infection. These findings are in some way unexpected considering that IBD is a chronic inflammatory state of the gastrointestinal tract. We herein discuss how the receptor for advanced glycation end-products (RAGE) axis activation as well as the cross-talk with the renin-angiotensin system are dampened by the high expression of soluble forms of both RAGE and angiotensin-converting enzyme 2. |
| Publish Date |
2021-05-13 10:05 |
| Citation |
Rojas A, Schneider I, Lindner C, Gonzàlez I, Morales MA. Receptor for advanced glycation end-products axis and COVID-19 in inflammatory bowel diseases: A dangerous liaison? World J Gastroenterol 2021; 27(19): 2270-2280 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i19/2270.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i19.2270 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
